The effect of an anti-inflammatory pentapeptide produced by Entamoeba histolytica on gene expression in the U-937 monocytic cell line

Inflammation Research

Volumn 57, Issue 4, 2008, Pages 145-150

  Silva Garcia R ^a   Estrada Garcia I ^b   Ramos Payan R ^b   Torres Salazar, A ^c   Morales Martinez M E ^a   Arenas Aranda, D ^a   Gimenez Scherer J A ^a   Blanco Favela, F ^a   Rico Rosillo, M G ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Cytokines; Gene expression; Inflammation; Microarrays; Pentapeptide

Indexed keywords

CYTOKINE; MONOCYTE LOCOMOTION INHIBITORY FACTOR; PENTAPEPTIDE; RECEPTOR; RNA;

ARTICLE; CELL FUNCTION; CELL STRAIN U937; ENTAMOEBA HISTOLYTICA; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANIMALS; CYTOKINES; ENTAMOEBA HISTOLYTICA; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MODELS, BIOLOGICAL; MONOCYTES; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGOPEPTIDES; U937 CELLS;

EID: 42649132139     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-6199-y     Document Type: Article

References (43)

1. Pérez-Tamayo R, Brandt H. Amebiasis. In: M Rojas (ed), Pathology of protozoan and helminthic disease. Williams & Wilkins-Baltimore, 1971, pp. 145-188.
2. Sepúlveda B, Martínez-Palomo A. Immunology of amebiasis by Entamoeba histolytica. In: Cohen S, Warren KS (eds), Immunology of parasitic diseases. Blackwell-Oxford, 1982, p. 170.
3. Kretschmer R, Salinas M, López-Osuna M, Ávila M. Efecto de Entamoeba histolytica sobre la quimiotaxis de monocitos humanos. Arch Invest Méd 1980; 11: 147-51.
4. Kretschmer R, Collado M, Pacheco G, Salinas M, López-Osuna M, Leucona M et al. Inhibition of human monocyte locomotion by products of axenically grown Entamoeba histolytica. Parasite Immunol 1985; 5: 527-43.
5. Kretschmer R, Castro E, Arellano J, Pacheco G. In vitro studies on the interaction of human monocytes and the monocyte locomotion inhibitory factor produced by Entamoeba histolytica. Arch Invest Med 1986; 17: 243-6.
6. Rico G, Díaz-Guerra O, Giménez-Scherer J, Kretschmer R. Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon the respiratory burst of human leukocytes. Arch Med Res 1992; 23(2): 157-9.
7. Rico G, Arellano J, Kretschmer R. The monocyte locomotion inhibitory factor produced by Entamoeba histolytica does not inhibit the locomotion of human eosinophils. Parasitol Res 1998; 84(6): 522-3.
8. Rico G, Leandro E, Rojas S, Giménez-Scherer J. The monocyte locomotion inhibitory factor produced by Entamoeba histolytica inhibits induced nitric oxide production in human leukocytes. Parasitol Res 2003; 90(4): 264-7.
9. Kretschmer R, Castro E, Pacheco G, Rico G, Díaz-Guerra O, Arellano J. The role of mannose in the receptor of the monocyte locomotion inhibitory factor produced by Entamoeba histolytica. Parasitol Res 1991; 77(5): 374-8.
10. Giménez-Scherer J, Pacheco G, Cruz de Lavín E, Hernández JP, Merchant M, Kretschmer R. Ultrastructural changes associated with the inhibition of monocyte chemotaxis caused by products of axenically grown Entamoeba histolytica. Lab Invest 1987; 57(1): 45-51.
11. Rico G, Díaz-Guerra O, Kretschmer R. Cyclic nucleotide changes induced in human leukocytes by a product of axenically grown Entamoeba histolytica that inhibits human monocyte locomotion. Parasite Res 1995; 81(2): 158-62.
12. Giménez-Scherer J, Rico G, Fernández-Díez J, Kretschmer R. Inhibition of contact cutaneous delayed hypersensitivity reactions to DNCB in guinea pigs by the Monocyte Locomotion Inhibitory Factor (MLIF) produced by axenically grown Entamoeba histolytica. Arch Med Res 1997; 28: 237-8.
13. Giménez-Scherer J, Arenas E, Díaz L, Rico G, Fernández J, Kretschmer R. Effect of the Monocyte Locomotion Inhibitory Factor (MLIF) Produced by Entamoeba histolytica on the Expression of Cell Adhesion Molecules (CAMs) in the Skin of Guinea Pigs. Arch Med Res 2000; 31: 92-3.
14. Luster A, Alon R, Ulrich H. Immune cell migration in inflammation: present and future therapeutic targets. Nature Immunol 2005; 6(12): 1182-90.
15. Han J, Ulevitch R. Limiting inflammatory response during activation of innate immunity. Nature Immunol 2005; 6(12): 1198-205.
16. DeRisi J, Iyer V, Brown P. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 1997; 278(5338): 680-6.
17. Bertucci F, Bernard K, Ioriod B, Yi-Chung Ch, Granjeaud S, Birnbaum D et al. Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum Mol Gen 1999; 8(9): 1715-22.
18. Ramos-Payan R, Aguilar-Medina M, Estrada-Parra S, Gonzálezy- Merchand, Favila-Castillo L, Monroy-Ostria A et al. Quantification of Cytokine Gene Expresión Using an Economical Real-Time Polymerase Chain Reaction Method Based on SYBR Green I. Scand J Immunol 2003; 57: 439-45
19. Díaz UR, Al-Shahrour F, Dopazo J. The Use of GO Terms to Understand the Biological Significance of Microarray Differential Gene Expression Data. 2003 http//bioinfo.cnio.es/docus/papers/thechreports.html
20. Soldatova L, King R. Are the current ontologies in biology good ontologies?. Nat Biotech 2005; 23(9): 1095-8.
21. Busold C, Winter S, Hauser N, Bauer A, Dippon J, Hoheisel J, et al. Integration of GO annotations in Correspondence Analysis: facilitating the interpretation of microarray data. Bioinformatics 2005; 21(10): 2424-9.
22. Al-Shahrour F, Minguez F, Vaqueriza J, Conde L, Dopazo J. BABELOMICS: a suite of web-tools for functional annotation and analysis of group of genes in high-throughput experiments. Nucleic Acids Research 2005; 33: W460-W4.
23. Al-Shahrour F, Minguez F, Tárraga J, Montaner D, Alloza E, Vaqueriza J et al. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Research 2006; 34: W472-W6.
24. Lawrence T, Gilroy D, Colville NP, Willoughby D. Possible new role for NF-kB in the resolution of inflammation. Nature Med 2001; 7(12): 1291-7.
25. Ghosh S, Karin M. Missing pieces in the NF-kB puzzle. Review. Cell 2002; 109: 81-96.
26. Cobb M, Goldsmith E. How MAP kinases are regulated. J Biol Chem 1995; 270(25): 14843-6.
27. Kaminska B. Mapk signaling pathways as molecular target for antiinflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochem Biophys Acta 2005; 1754(1): 253-62.
28. Utrera BD, Velázquez RJ, Enciso A, Muñoz Cruz S, Rico RG, Curiel QE et al. An anti-inflammatory oligopeptide produced by Entamoeba histolytica down-regulates the expression of pro-inflammatory chemokines. Parasite Immunol 2003; 25(10): 475-82.
29. Velázquez JR, Utrera BD, Zentella A, García BE, Ledesma SY, Kretschmer RR. The amebic anti-inflammatory monocyte locomotion inhibitory factor (MLIF) modifies the NF-kB nuclear translocation in human monocytes. Eur Cytokine Netw 2003; 14: 64.
30. Ledesma SY. Efecto modulador del FILM sobre la regulación de IL-1β en la línea celular U937 Tesis de Maestría, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional. México D. F.
31. Wolpe S, Davatelis G, Sherry B, Beautler B, Hess D, Ngoyen H et al. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 1988; 167(2): 570-81.
32. Kennedy KJ, Karpus WJ. Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis. J Clin Immunol 1999; 19(5): 273-9.
33. Zou W, Borvak J, Marcher F, Wei S, Galanaud P, Emilie D et al. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12. J Immunol 2000; 165(8): 4388-96.
34. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 1999; 274(45): 31868-74.
35. de Waal Malefyt R, Abrams J, Bennett B, Figdor C, Devries J. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocyte: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174(5): 1209-20.
36. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992; 267(32): 23301-8.
37. Moore KW, O'Garra A, de Waal MR, Vieira P, Mosmann T. Interleukin -10. Annu Rev Immunol 1993; 11: 165-90.
38. Cassatella M, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) Inhibits the Release of Proinflammatory Cytokines from Human Polymorphonuclear Leukocytes Evidence for an Autocrine Role of Tumor Necrosis Factor and IL-1 beta in Mediating the Production of IL-8 triggered by Lipopolysaccharide. J Exp Med 1993; 178(6): 2207-11.
39. Takanaski S, Nonaka R, Xing Z, O'byrne P, Dolovich J, Jordana M. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994; 180(2): 711-5.
40. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by Interleukin-10. J Exp Med 1991; 174(6): 1549-55.
41. Gazzinelli R, Oswald I, James S, Sher A. IL-10 Inhibits Parasite Killing and Nitrogen Oxide Production by INF-gamma-Activated Macrophages. J Immunol 1992; 148(6): 1792-6.
42. Cunha F, Moncada S, Liew F. Interleukin 10 (IL-10) Inhibits the induction of Nitric Oxide Synthasa by Interferon gamma in Murine Macrophages. Biochem. Biophys Res Commun 1992; 182(3): 1155-9.
43. Niiro H, Otsuka T, Kuga S, Nemoto Y, Abe M, Hara N, et al. IL-10 Inhibits Prostaglandins E(2) Production by Lipopolysacharide-Stimulated monocytes. Int Immunol 1994; 6(4): 661-4.